Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-16-095858
Filing Date
2016-04-22
Accepted
2016-04-22 17:00:39
Documents
5
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A v437485_10ka.htm 10-K/A 340380
2 EXHIBIT 31.1 v437485_ex31-1.htm EX-31.1 9574
3 EXHIBIT 31.2 v437485_ex31-2.htm EX-31.2 9677
4 EXHIBIT 32.1 v437485_ex32-1.htm EX-32.1 4317
5 EXHIBIT 32.2 v437485_ex32-2.htm EX-32.2 4127
  Complete submission text file 0001144204-16-095858.txt   369325
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33357 | Film No.: 161587183
SIC: 2836 Biological Products, (No Diagnostic Substances)